乳房画像診断市場：技術別（電離、非電離）、製品別（乳房画像診断システム、ソフトウェアおよびサービス、付属品）、エンドユーザー別（病院および診療所、画像診断センター、乳房ケアセンター）-2028年までの世界予測

Breast Imaging Market by Technology (Ionizing, Non-ionizing), Product (Breast Imaging Systems, Software and Services, Accessories), End User (Hospitals and Clinics, Diagnostic Imaging Centers, Breast Care Centers) - Global Forecast to 2028

世界の乳房画像市場は、2023年の44億米ドルから2028年には66億米ドルに達すると予測され、2023年から2028年までの年平均成長率は8.5%である。乳がん研究を支援する資金や助成金の増加、有利な償還シナリオなどの... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年6月28日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	267	281	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界の乳房画像市場は、2023年の44億米ドルから2028年には66億米ドルに達すると予測され、2023年から2028年までの年平均成長率は8.5%である。乳がん研究を支援する資金や助成金の増加、有利な償還シナリオなどの要因が、この市場の成長を高めている。

"イオン化乳房画像技術セグメントが2022年に市場で最大のシェアを占めた"
技術に基づき、乳房イメージング市場は電離性乳房イメージング技術と非電離性乳房イメージング技術に区分される。電離性乳房イメージング技術分野が2022年に最大の市場シェアを占めた。このセグメントの大きなシェアは、技術的に先進的なシステムの発売とエンドユーザーによる乳房イメージングシステムの使用増加によるものである。

"ソフトウェア＆サービス分野は予測期間中に最も高いCAGRを記録すると予測されている"
乳房イメージング市場は、製品別に乳房イメージングシステム、ソフトウェア＆サービス、アクセサリーに区分される。ソフトウェア＆サービス分野は、2023年から2028年にかけて最も高いCAGRを記録すると予測されている。乳房画像診断装置の使用増加、がん研究への注目の高まり、研究支援のための資金調達の増加などの要因が市場成長を促進している。

"アジア太平洋地域の市場は予測期間中に最も高い成長を目撃すると予想される"
APAC地域の乳房画像市場は、主に医療インフラの進化と同地域における主要プレイヤーの注力度の高まりにより、予測期間中にCAGRを記録すると予測されている。中国、インド、韓国などの新興国の医療インフラは急速なペースで進化しており、病院や診断センターによる高度画像システム（MRI、3D乳房トモシンセシス、自動全乳房超音波検査などの高度乳房画像システムを含む）への大規模な投資につながっている。これらの要因は、この地域における乳房画像診断市場の成長を促進すると予想される。

本レポートで参照した主要参入企業の内訳は以下の通りである：
- 企業タイプ別ティア1-48％、ティア2-36％、ティア3-16
- 役職別Cレベル-10%、ディレクターレベル-14%、その他-76
- 地域別北米-40%、欧州-32%、アジア太平洋地域-20%、中南米-5%、中東・アフリカ-3

乳房画像市場の主要企業は、GE Healthcare（米国）、Hologic, inc.（米国）、Siemens Healthcare GmbH（ドイツ）、Koninklijke Philips N.V.（オランダ）、富士フイルムホールディングス（日本）、キヤノン（日本）、Aurora Healthcare US Corp.（米国）、Planmed Oy（フィンランド）、Allengers（インド）などである。

調査範囲

本レポートでは、乳房画像市場を技術、製品、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーの競争環境の詳細を提供します。さらに、微小市場の成長動向を分析し、主要5地域（およびこれらの地域の各国）に関する市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、乳房イメージング市場全体とサブセグメントに関する収益数の最も近い近似値に関する情報を提供し、市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より良い事業の位置づけと適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、関係者が市場の脈拍を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供するのに役立ちます。

本レポートは、以下のポイントに関する洞察を提供します：
- 乳房画像診断市場の成長に影響を与える主な促進要因（乳がん罹患率の増加、乳がんの早期発見に関する意識の高まり、官民投資・資金・助成金の増加、乳房画像診断モダリティの技術進歩、高齢者人口の増加）、抑制要因（厳しい規制承認手続き、機器の高コスト）、機会（契約ベースの診断ソリューションおよびモバイルソリューション、新興国における機会増加）、課題（乳がんスクリーニングおよび診断におけるエラー、放射線被曝の副作用、改装型画像診断システムの採用増加）の分析
- 製品開発/イノベーション：乳房画像診断市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細な洞察
- 市場開発：有利な市場に関する包括的情報-本レポートは様々な地域の乳房画像市場を分析しています。
- 市場の多様化：乳房画像処理市場における新製品＆サービス、未開拓地域、最近の開発、投資に関する詳細情報
- 競合評価：GE Healthcare社（米国）、Hologic, inc.社（米国）、Siemens Healthcare GmbH社（ドイツ）、Koninklijke Philips N.V.社（オランダ）、富士フイルムホールディングス株式会社（日本）などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。

ページTOPに戻る

1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS AND EXCLUSIONS 34
1.3 MARKET SEGMENTATION 35
1.3.1 MARKETS COVERED 35
1.3.2 REGIONS COVERED 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
1.6 LIMITATIONS 36
1.7 STAKEHOLDERS 37
1.8 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 1 BREAST IMAGING MARKET: RESEARCH DESIGN METHODOLOGY 38
2.1.1 SECONDARY RESEARCH 39
2.1.2 PRIMARY RESEARCH 40
2.1.2.1 Primary sources 40
2.1.2.2 Key industry insights 41
2.1.2.3 Breakdown of primaries 41
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 41
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 42
2.2 RECESSION IMPACT ANALYSIS 42
2.3 MARKET SIZE ESTIMATION 42
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 43
2.3.1 BOTTOM-UP APPROACH 44
2.3.1.1 Approach 1: Company revenue estimation approach 44
FIGURE 5 MARKET SIZE ESTIMATION FOR BREAST IMAGING MARKET: APPROACH 1 (COMPANY REVENUE ESTIMATION) 44
FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF HOLOGIC, INC. 45
2.3.1.2 Approach 2: Customer-based market estimation 45
FIGURE 7 BOTTOM-UP APPROACH FOR MARKET SIZE ESTIMATION: BREAST IMAGING MARKET 46
2.3.1.3 Growth forecast 46
2.3.1.4 CAGR projections 47
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47
2.4 DATA TRIANGULATION APPROACH 48
FIGURE 9 DATA TRIANGULATION METHODOLOGY 48
2.5 MARKET SHARE ESTIMATION 48
2.6 ASSUMPTIONS 49
2.7 RISK ASSESSMENT 49
2.7.1 RISK ASSESSMENT: BREAST IMAGING MARKET 49
2.8 GROWTH RATE ASSUMPTIONS 50
3 EXECUTIVE SUMMARY 51
FIGURE 10 BREAST IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 51
FIGURE 11 BREAST IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 52
FIGURE 12 BREAST IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 52
FIGURE 13 BREAST IMAGING MARKET: GEOGRAPHIC SNAPSHOT 53
4 PREMIUM INSIGHTS 54
4.1 BREAST IMAGING MARKET OVERVIEW 54
FIGURE 14 RISING PREVALENCE OF BREAST CANCER TO DRIVE GROWTH 54
4.2 EUROPE: MAMMOGRAPHY MARKET, BY TYPE 55
FIGURE 15 3D BREAST TOMOSYNTHESIS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN EUROPEAN MAMMOGRAPHY MARKET 55
4.3 NORTH AMERICA: BREAST IMAGING MARKET, BY PRODUCT 55
FIGURE 16 SOFTWARE AND SERVICES SEGMENT TO REGISTER SIGNIFICANT GROWTH IN NORTH AMERICAN MARKET DURING FORECAST PERIOD 55
4.4 ASIA PACIFIC: BREAST IMAGING MARKET, BY END USER 56
FIGURE 17 HOSPITALS AND CLINICS SEGMENT TO CONTINUE TO HOLD LARGEST SHARE IN ASIA PACIFIC MARKET 56
4.5 GEOGRAPHIC SNAPSHOT OF BREAST IMAGING MARKET 56
FIGURE 18 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 19 BREAST IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Growing incidence of breast cancer 58
FIGURE 20 NUMBER OF NEW BREAST CANCER CASES IN 2020, BY KEY COUNTRY 58
5.2.1.2 Increasing public-private investments, funding, and grants 58
5.2.1.3 Growing awareness of early breast cancer detection 59
5.2.1.4 Technological advancements in breast imaging modalities 59
5.2.1.5 Growing geriatric population 60
5.2.2 RESTRAINTS 60
5.2.2.1 High cost of breast imaging systems 60
5.2.2.2 Stringent regulatory approval procedures 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth potential in emerging economies 61
5.2.3.2 Contract-based diagnostic solutions and mobile solutions 61
5.2.4 CHALLENGES 62
5.2.4.1 Side effects of radiation exposure 62
5.2.4.2 Errors in breast cancer screening and diagnosis 62
5.2.4.3 Increasing adoption of refurbished imaging systems 62
5.3 PORTER’S FIVE FORCES ANALYSIS 63
TABLE 1 BREAST IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 63
5.3.1 THREAT OF NEW ENTRANTS 63
5.3.2 THREAT OF SUBSTITUTES 63
5.3.3 BARGAINING POWER OF SUPPLIERS 63
5.3.4 BARGAINING POWER OF BUYERS 63
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 64
5.4 TRADE ANALYSIS FOR BREAST IMAGING EQUIPMENT 64
TABLE 2 IMPORT DATA FOR BREAST IMAGING/MAMMOGRAPHY, BY COUNTRY, 2018–2022 (USD THOUSAND) 64
TABLE 3 EXPORT DATA FOR BREAST IMAGING/MAMMOGRAPHY, BY COUNTRY, 2018–2022 (USD THOUSAND) 65
5.5 PATENT ANALYSIS 66
FIGURE 21 TOP 10 PATENT APPLICANTS FOR BREAST IMAGING (JANUARY 2012–DECEMBER 2022) 66
FIGURE 22 TOP 10 PATENT APPLICANTS FOR MAMMOGRAPHY (JANUARY 2012–DECEMBER 2022) 67
5.6 ECOSYSTEM COVERAGE: PARENT MARKET 68
5.7 VALUE CHAIN ANALYSIS 68
5.7.1 RESEARCH & DEVELOPMENT 68
5.7.2 MANUFACTURING & ASSEMBLY 68
5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 68
FIGURE 23 BREAST IMAGING MARKET: VALUE CHAIN ANALYSIS 69
5.8 SUPPLY CHAIN ANALYSIS 69
5.8.1 PROMINENT COMPANIES 69
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES 69
5.8.3 END USERS 69
FIGURE 24 BREAST IMAGING MARKET: SUPPLY CHAIN ANALYSIS 70
5.9 PRICING TREND ANALYSIS 70
TABLE 4 AVERAGE SELLING PRICE FOR MAJOR BREAST IMAGING EQUIPMENT 70
5.10 TECHNOLOGY ANALYSIS 71
5.11 REGULATORY LANDSCAPE 71
5.11.1 NORTH AMERICA 71
5.11.1.1 US 71
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 72
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 72
5.11.1.2 Canada 72
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73
5.11.2 EUROPE 73
5.11.3 ASIA PACIFIC 74
5.11.3.1 Japan 74
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74
5.11.3.2 China 74
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 75
5.11.3.3 India 76
5.12 REIMBURSEMENT SCENARIO 77
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES IN US (AS OF 2022) 77
5.13 CASE STUDIES 78
5.13.1 TECHNOLOGICAL CHALLENGES 78
TABLE 11 CASE STUDY 1: BETTER VISUALIZATION OF BREAST IMAGES IN WOMEN WITH DENSE BREAST TISSUE 78
5.14 KEY CONFERENCES AND EVENTS (2023–2024) 78
TABLE 12 BREAST IMAGING MARKET: LIST OF MAJOR CONFERENCES AND EVENTS 78
6 BREAST IMAGING MARKET, BY TECHNOLOGY 80
6.1 INTRODUCTION 81
TABLE 13 BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 81
6.2 IONIZING BREAST IMAGING TECHNOLOGIES 81
TABLE 14 IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
6.2.1 MAMMOGRAPHY 82
TABLE 15 MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
TABLE 16 MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 17 NORTH AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 18 EUROPE: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 19 ASIA PACIFIC: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 20 LATIN AMERICA: MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 21 MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 85
TABLE 22 MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 85
6.2.1.1 Full-field digital mammography (FFDM) 86
6.2.1.1.1 Use of lower radiation doses to drive growth 86
TABLE 23 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 24 NORTH AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 25 EUROPE: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 26 ASIA PACIFIC: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 27 LATIN AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 28 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 89
TABLE 29 FULL-FIELD DIGITAL MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 89
6.2.1.2 Analog mammography 89
6.2.1.2.1 High spatial resolution and low installation cost to boost adoption 89
TABLE 30 ANALOG MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 31 NORTH AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 32 EUROPE: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 33 ASIA PACIFIC: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 34 LATIN AMERICA: ANALOG MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 35 ANALOG MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 93
TABLE 36 ANALOG MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 93
6.2.1.3 3D breast tomosynthesis 93
6.2.1.3.1 3D breast tomosynthesis to witness highest growth in mammography market 93
TABLE 37 3D BREAST TOMOSYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 38 NORTH AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 39 EUROPE: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 40 ASIA PACIFIC: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 41 LATIN AMERICA: 3D BREAST TOMOSYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 42 3D BREAST TOMOSYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION) 96
TABLE 43 3D BREAST TOMOSYNTHESIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 97
6.2.1.4 Contrast-enhanced mammography (CEM) 97
6.2.1.4.1 Affordability over breast MRI and improved diagnostic accuracy to drive growth 97
TABLE 44 CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 45 NORTH AMERICA: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 46 EUROPE: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 47 ASIA PACIFIC: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 48 LATIN AMERICA: CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 49 CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 100
TABLE 50 CONTRAST-ENHANCED MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 101
6.2.2 POSITRON EMISSION MAMMOGRAPHY (PEM) 101
6.2.2.1 Higher sensitivity and accuracy to drive adoption 101
TABLE 51 POSITRON EMISSION MAMMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 52 NORTH AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 53 EUROPE: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 54 ASIA PACIFIC: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 55 LATIN AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 56 POSITRON EMISSION MAMMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 104
TABLE 57 POSITRON EMISSION MAMMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 105
6.2.3 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT) 105
6.2.3.1 Combined scans from PET and CT offer more accurate results 105
TABLE 58 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 59 NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 60 EUROPE: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 61 ASIA PACIFIC: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 62 LATIN AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 63 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 108
TABLE 64 POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 109
6.2.4 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI) 109
6.2.4.1 High sensitivity to drive growth 109
TABLE 65 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 66 NORTH AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 67 EUROPE: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 68 ASIA PACIFIC: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 69 LATIN AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 70 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 112
TABLE 71 MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 113
6.2.5 CONE-BEAM COMPUTED TOMOGRAPHY (CBCT) 113
6.2.5.1 CBCT segment to witness stable growth during forecast period 113
TABLE 72 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 73 NORTH AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 74 EUROPE: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 75 ASIA PACIFIC: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 76 LATIN AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 77 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 116
TABLE 78 CONE-BEAM COMPUTED TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 117
6.3 NON-IONIZING BREAST IMAGING TECHNOLOGIES 117
TABLE 79 NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
6.3.1 BREAST ULTRASOUND 118
6.3.1.1 Rising awareness and easy availability of ultrasound devices for breast imaging to drive growth 118
TABLE 80 BREAST ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 81 NORTH AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 82 EUROPE: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 83 ASIA PACIFIC: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 84 LATIN AMERICA: BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 85 BREAST ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 121
TABLE 86 BREAST ULTRASOUND MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 122
6.3.2 BREAST MRI 122
6.3.2.1 Technological advancements in breast MRI to drive growth 122
TABLE 87 BREAST MRI MARKET, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 88 NORTH AMERICA: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 89 EUROPE: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 90 ASIA PACIFIC: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 91 LATIN AMERICA: BREAST MRI MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 92 BREAST MRI MARKET, BY END USER, 2021–2028 (USD MILLION) 125
TABLE 93 BREAST MRI MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 125
6.3.3 AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU) 126
6.3.3.1 AWBU helps spot small cancers in mammograms of dense breasts 126
TABLE 94 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 95 NORTH AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 96 EUROPE: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 97 ASIA PACIFIC: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 98 LATIN AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 99 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION) 129
TABLE 100 AUTOMATED WHOLE-BREAST ULTRASOUND MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 129
6.3.4 BREAST THERMOGRAPHY 130
6.3.4.1 Rising popularity due to reduced exposure to harmful radiation to boost adoption 130
TABLE 101 BREAST THERMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 102 NORTH AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 103 EUROPE: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 104 ASIA PACIFIC: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 105 LATIN AMERICA: BREAST THERMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 106 BREAST THERMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 133
TABLE 107 BREAST THERMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 133
6.3.5 ELECTRIC IMPEDANCE TOMOGRAPHY 133
6.3.5.1 Affordability and quick results to drive growth 133
TABLE 108 ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 109 NORTH AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 110 EUROPE: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 111 ASIA PACIFIC: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 112 LATIN AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 113 ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY END USER, 2021–2028 (USD MILLION) 136
TABLE 114 ELECTRIC IMPEDANCE TOMOGRAPHY MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 137
6.3.6 OPTICAL IMAGING 137
6.3.6.1 High sensitivity, easy accessibility, and lower cost to support growth 137
TABLE 115 OPTICAL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 116 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 117 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 118 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 119 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 120 OPTICAL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 140
TABLE 121 OPTICAL IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
7 BREAST IMAGING MARKET, BY PRODUCT 141
7.1 INTRODUCTION 142
TABLE 122 BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
7.2 BREAST IMAGING SYSTEMS 142
7.2.1 SIGNIFICANT TECHNOLOGICAL DEVELOPMENTS TO FUEL GROWTH 142
TABLE 123 BREAST IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
7.3 SOFTWARE AND SERVICES 143
7.3.1 INTRODUCTION OF NOVEL IMAGING SOFTWARE TO SUPPORT GROWTH 143
TABLE 124 BREAST IMAGING SOFTWARE AND SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 144
7.4 ACCESSORIES 144
7.4.1 INCREASING ADOPTION OF BREAST IMAGING EQUIPMENT TO BOOST GROWTH 144
TABLE 125 BREAST IMAGING ACCESSORIES MARKET, BY REGION, 2021–2028 (USD MILLION) 145
8 BREAST IMAGING MARKET, BY END USER 146
8.1 INTRODUCTION 147
TABLE 126 BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 147
8.2 HOSPITALS AND CLINICS 147
8.2.1 RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST GROWTH 147
TABLE 127 BREAST IMAGING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021–2028 (USD MILLION) 148
8.3 DIAGNOSTIC IMAGING CENTERS 148
8.3.1 RISING NUMBER OF PRIVATE IMAGING CENTERS CONTRIBUTING TO GROWTH 148
TABLE 128 BREAST IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021–2028 (USD MILLION) 149
8.4 BREAST CARE CENTERS 149
8.4.1 INCREASING INCLINATION TOWARD BREAST CARE CENTERS OBSERVED IN DEVELOPED COUNTRIES 149
TABLE 129 BREAST IMAGING MARKET FOR BREAST CARE CENTERS, BY REGION, 2021–2028 (USD MILLION) 150
8.5 OTHER END USERS 150
TABLE 130 BREAST IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 151
9 BREAST IMAGING MARKET, BY REGION 152
9.1 INTRODUCTION 153
TABLE 131 BREAST IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 153
9.2 NORTH AMERICA 153
FIGURE 25 NORTH AMERICA: BREAST IMAGING MARKET SNAPSHOT 154
TABLE 132 NORTH AMERICA: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 133 NORTH AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 155
TABLE 134 NORTH AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 135 NORTH AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 136 NORTH AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 137 NORTH AMERICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 157
TABLE 138 NORTH AMERICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 157
9.2.1 US 157
9.2.1.1 US to dominate North American breast imaging market during forecast period 157
TABLE 139 US: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 158
TABLE 140 US: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 141 US: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 142 US: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
9.2.2 CANADA 160
9.2.2.1 Increasing incidence of breast cancer and favorable government guidelines to support growth 160
TABLE 143 CANADA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 161
TABLE 144 CANADA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 145 CANADA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 146 CANADA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
9.3 EUROPE 163
TABLE 147 EUROPE: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 148 EUROPE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 163
TABLE 149 EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 150 EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 151 EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 152 EUROPE: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 165
TABLE 153 EUROPE: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 166
9.3.1 GERMANY 166
9.3.1.1 Rising utilization of ionizing and non-ionizing imaging technologies to boost growth 166
TABLE 154 GERMANY: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 167
TABLE 155 GERMANY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 156 GERMANY: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 157 GERMANY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
9.3.2 FRANCE 169
9.3.2.1 Growing government initiatives and modernization of healthcare infrastructure fueling growth 169
TABLE 158 FRANCE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 169
TABLE 159 FRANCE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 160 FRANCE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 161 FRANCE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
9.3.3 UK 171
9.3.3.1 Growing funding opportunities for supporting cancer research to drive growth 171
TABLE 162 UK: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 172
TABLE 163 UK: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 164 UK: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 165 UK: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
9.3.4 ITALY 174
9.3.4.1 Evolving regulatory scenario for breast imaging and rising incidence of cancer to drive growth 174
TABLE 166 ITALY: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 174
TABLE 167 ITALY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 168 ITALY: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 169 ITALY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
9.3.5 SPAIN 176
9.3.5.1 Growing geriatric population to drive growth 176
TABLE 170 SPAIN: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 177
TABLE 171 SPAIN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 172 SPAIN: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 173 SPAIN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
9.3.6 REST OF EUROPE 179
TABLE 174 REST OF EUROPE: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 175 REST OF EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 176 REST OF EUROPE: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 177 REST OF EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
9.4 ASIA PACIFIC 181
FIGURE 26 ASIA PACIFIC: BREAST IMAGING MARKET SNAPSHOT 182
TABLE 178 ASIA PACIFIC: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 179 ASIA PACIFIC: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 183
TABLE 180 ASIA PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 181 ASIA PACIFIC: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 182 ASIA PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 183 ASIA PACIFIC: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 185
TABLE 184 ASIA PACIFIC: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 185

9.4.1 JAPAN 185
9.4.1.1 Rising breast cancer cases and presence of universal healthcare reimbursement scenario to fuel growth 185
TABLE 185 JAPAN: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 186
TABLE 186 JAPAN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 187 JAPAN: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 188 JAPAN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
9.4.2 CHINA 188
9.4.2.1 Government initiatives for healthcare development to fuel growth 188
TABLE 189 CHINA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 189
TABLE 190 CHINA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 189
TABLE 191 CHINA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 192 CHINA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
9.4.3 INDIA 191
9.4.3.1 Rising government initiatives focused on improving female health to drive growth 191
TABLE 193 INDIA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 191
TABLE 194 INDIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 195 INDIA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 196 INDIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
9.4.4 AUSTRALIA 193
9.4.4.1 Rising research funding and awareness campaigns to support growth 193
TABLE 197 AUSTRALIA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 194
TABLE 198 AUSTRALIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 199 AUSTRALIA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 200 AUSTRALIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
9.4.5 SOUTH KOREA 196
9.4.5.1 Rising government initiatives to drive growth 196
TABLE 201 SOUTH KOREA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 196
TABLE 202 SOUTH KOREA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 203 SOUTH KOREA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 204 SOUTH KOREA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
9.4.6 REST OF ASIA PACIFIC 198
TABLE 205 REST OF ASIA PACIFIC: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 198
TABLE 206 REST OF ASIA PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 207 REST OF ASIA PACIFIC: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 208 REST OF ASIA PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
9.5 LATIN AMERICA 200
TABLE 209 LATIN AMERICA: BREAST IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 200
TABLE 210 LATIN AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 201
TABLE 211 LATIN AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 212 LATIN AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 213 LATIN AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 214 LATIN AMERICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 203
TABLE 215 LATIN AMERICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 203
9.5.1 BRAZIL 203
9.5.1.1 Rising modernization of healthcare facilities to drive growth 203
TABLE 216 BRAZIL: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 204
TABLE 217 BRAZIL: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 218 BRAZIL: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 219 BRAZIL: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
9.5.2 MEXICO 206
9.5.2.1 Availability of advanced care and increasing awareness programs to fuel growth 206
TABLE 220 MEXICO: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 206
TABLE 221 MEXICO: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 222 MEXICO: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 223 MEXICO: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 208
9.5.3 REST OF LATIN AMERICA 208
TABLE 224 REST OF LATIN AMERICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 209
TABLE 225 REST OF LATIN AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 226 REST OF LATIN AMERICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 227 REST OF LATIN AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
9.6 MIDDLE EAST & AFRICA 211
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE GROWTH 211
TABLE 228 MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 211
TABLE 229 MIDDLE EAST & AFRICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 230 MIDDLE EAST & AFRICA: MAMMOGRAPHY MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 231 MIDDLE EAST & AFRICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 232 MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213
TABLE 233 MIDDLE EAST & AFRICA: BREAST IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 214
10 COMPETITIVE LANDSCAPE 215
10.1 OVERVIEW 215
10.2 RIGHT TO WIN 215
10.3 STRATEGIES OF KEY PLAYERS 216
FIGURE 27 KEY DEVELOPMENTS IN BREAST IMAGING MARKET 216
10.4 REVENUE SHARE ANALYSIS 216
FIGURE 28 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS IN BREAST IMAGING MARKET (2020–2022) 216
10.5 MARKET SHARE ANALYSIS 217
FIGURE 29 GE HEALTHCARE HELD LEADING POSITION IN BREAST IMAGING MARKET IN 2022 217
TABLE 234 BREAST IMAGING MARKET: DEGREE OF COMPETITION 217
10.6 COMPANY EVALUATION MATRIX (2022) 218
10.6.1 VENDOR INCLUSION CRITERIA 218
10.6.2 STARS 219
10.6.3 PERVASIVE PLAYERS 219
10.6.4 EMERGING LEADERS 219
10.6.5 PARTICIPANTS 219
FIGURE 30 BREAST IMAGING MARKET: COMPANY EVALUATION MATRIX, 2022 220
10.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022) 221
10.7.1 PROGRESSIVE COMPANIES 221
10.7.2 STARTING BLOCKS 221
10.7.3 RESPONSIVE COMPANIES 221
10.7.4 DYNAMIC COMPANIES 221
FIGURE 31 BREAST IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 222
10.8 COMPETITIVE BENCHMARKING 223
TABLE 235 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BREAST IMAGING MARKET 223
10.9 COMPETITIVE SCENARIO AND TRENDS 223
10.9.1 PRODUCT LAUNCHES 223
TABLE 236 BREAST IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023 223
10.9.2 DEALS 225
TABLE 237 BREAST IMAGING MARKET: DEALS, JANUARY 2020–MAY 2023 225
10.9.3 OTHER DEVELOPMENTS 227
TABLE 238 BREAST IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023 227

ページTOPに戻る

Table of Contents

Summary

The global breast imaging market is projected to reach USD 6.6 billion by 2028 from USD 4.4 billion in 2023, at a CAGR of 8.5% from 2023 to 2028. Factors such as increasing funding and grants supporting breast cancer research and favorable reimbursement scenario are responsible for the increasing growth of this market.

“The ionizing breast imaging technologies segment held the largest share of the market in 2022”
Based on technology, the breast imaging market is segmented into ionizing breast imaging technologies and non-ionizing breast imaging technologies. The ionizing breast imaging technologies segment held the largest market share in 2022. The large share of this segment can be attributed to the launch of technologically advanced systems and rising use of breast imaging systems by the end users.

“The software & services segment is projected to register the highest CAGR during the forecast period”
Based on product, the breast imaging market is segmented into breast imaging systems, software & services, and accessories. The software & services segment is projected to register the highest CAGR from 2023 to 2028. Factors such as the increasing use of breast imaging equipment, rising focus on cancer research, and increasing fundings to support research are driving the market growth.

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The breast imaging market in the APAC region is expected to register a CAGR during the forecast period, primarily due to evolving healthcare infrastructure and increasing focus of major players in the region. The healthcare infrastructure in emerging economies, such as China, India, and South Korea, is evolving at a rapid pace, leading to major investments in advanced imaging systems (including advanced breast imaging systems such as MRI, 3D breast tomosynthesis, and automated whole-breast ultrasound) by hospitals and diagnostic centers. These factors are anticipated to fuel the growth of breast imaging market in this region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%

The prominent players in the breast imaging market are GE Healthcare (US), Hologic, inc. (US), Siemens Healthcare GmbH (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (US), Planmed Oy (Finland), and Allengers (India) among others.

Research Coverage

This report studies the breast imaging market based on technology, product, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall breast imaging market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
• Analysis of key drivers (growing incidence of breast cancer, increasing awareness on early detection of breast cancer, increasing public-private investments, funds, and grants, technological advancements in breast imaging modalities, growing geriatric population), restraints (stringent regulatory approval procedures, high cost of instruments), opportunities (contract-based diagnostic soluions and mobile solutions, and rising opportunities in emerging countries), and challenges (errors in breast cancer screening and diagnosis, side effects of radition exposure, increasing adoption of refurbished imaging systems) influencing the growth of the breast imaging market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the breast imaging market
• Market Development: Comprehensive information about lucrative markets–the report analyses the breast imaging market across varied regions
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the breast imaging market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like GE Healthcare (US), Hologic, inc. (US), Siemens Healthcare GmbH (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan).

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（clinics）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?